LABT Stock Catalyst: Lakewood-Amedex Biotherapeutics Inc. Granted Notice of Allowance for Antimicrobial Patent

Aug 31, 2026 · 3:59pm ET

The company received a Notice of Allowance for a U.S. patent.

Max move

+69.5%

High of day $3.78

Sparker timei

3:59pm ET

LABT · Aug 31, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Lakewood-Amedex Biotherapeutics Inc. (Nasdaq: LABT) has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent titled "ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF".

The patent covers novel antimicrobial compounds and their applications, marking a significant advancement in the company's biotechnology portfolio.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time LABT sparks.

Download Sniper App →

Catch the next LABT-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →